Valor20202021202220232024Total de pasivos36.39 M35.88 M35.5 M34.11 M39.55 MCapital total57.15 M32.19 M15.3 M5.42 M-865 KTotal de pasivos y patrimonio neto93.54 M68.06 M50.8 M39.53 M38.68 MDeuda total23.85 M21.68 M23.53 M24.03 M27.29 MDeuda neta-64.37 M11.91 M18.17 M-6.85 M5.38 M
Pluri Inc
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.